Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(CSE:
DMED
)
0.0400
UNCHANGED
Streaming Delayed Price
Updated: 3:02 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about DMED
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
April 25, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
April 23, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
April 03, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO
March 20, 2024
BRAIN AGE® solution is part of the CERVAI™ Brain Health AI Platform
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
March 14, 2024
Potential $150,000 in non-dilutive funding support through IPON and IP Assist Programs
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution
March 11, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
February 28, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
January 17, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program
November 15, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
October 03, 2023
Program provides healthcare providers access to Diagnamed’s novel brain health AI platform
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™
September 13, 2023
A world first, CERVAI™ on track for commercialization in Q4-2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AI
June 20, 2023
CERVAI™ entering final development stage and readying for commercialization in Q4-2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
May 25, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States
May 17, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches “Health GenAI”, a New Division for Generative AI Healthcare Solutions
May 10, 2023
Focused on Health GenAI and CERVAI™, a generative AI brain health platform
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution
May 03, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Enters into License Agreement with University of Miami for Brain Health Platform for Integration with CERVAI™, a Brain Health AI Platform Leveraging Generative AI
February 22, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Prioritizes Development and Commercialization Initiatives for CERVAI™, a Brain Health AI Platform Leveraging Generative AI
February 14, 2023
CERVAI™ to be available in May 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Holdings Incorporates OpenAI’s ChatGPT into BRAIN AGE™ AI Product Suite
February 01, 2023
Brain Health Digital Platform to be available in May 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023
January 31, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
DiagnaMed Holdings Acquires Exclusive Rights to a Virtual Reality and Artificial Intelligence-based Neurodiagnostic System for Neurodegenerative Disease
November 15, 2022
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.